5-Azacytidine induces early stage apoptosis and promotes in vitro maturation by changing chromosomal construction in murine oocytes

Reprod Toxicol. 2013 Jun:37:56-61. doi: 10.1016/j.reprotox.2013.01.007. Epub 2013 Feb 8.

Abstract

As an anticancer drug, 5-azacytidine (5-AzaC) has been widely used to treat various cancers. To investigate the effect of 5-AzaC on mouse oocytes cultured in vitro, we have performed morphological and molecular biology studies to examine the behavior of chromosomes and oocyte development. In 5-AzaC-treated oocytes, chromosomes were decondensed and unstable. The mRNA levels of Caspase3, Caspase8, and Caspase9 increased with the occurrence of early stage apoptosis in oocytes following 5-AzaC treatment. Furthermore, the mRNA levels of Gdf9 and Bmp15 also increased with the corresponding morphological changes in 5-AzaC-treated oocytes. In conclusion, 5-AzaC not only induced early apoptosis through both extrinsic and intrinsic pathways, but also had a positive effect on the developmental competence of mouse oocytes during in vitro maturation. These effects may be due to changes in chromosomal construction induced by DNA hypomethylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimetabolites, Antineoplastic / toxicity*
  • Apoptosis / drug effects
  • Azacitidine / toxicity*
  • Caspases / genetics
  • Cell Growth Processes / drug effects
  • Cells, Cultured
  • Chromosomes / metabolism
  • Female
  • Mice
  • Oocytes / drug effects*
  • Oocytes / physiology
  • RNA, Messenger / metabolism

Substances

  • Antimetabolites, Antineoplastic
  • RNA, Messenger
  • Caspases
  • Azacitidine